Characteristics of the Patients
Characteristic . | No. of Patients (%) . |
---|---|
Median age (range) | 45 yr (18-60 yr) |
Sex | |
M | 126 (59%) |
F | 89 (41%) |
Histology (WF) | |
Diffuse large cell | |
Centroblastic | 73 (34%) |
Immunoblastic | 40 (19%) |
Others | 27 (13%) |
Diffuse mixed small and large cell | 43 (20%) |
Diffuse small cell | 8 (4%) |
Follicular large cell | 12 (6%) |
Lymphoblastic | 7 (3%) |
Diffuse small noncleaved cell | 5 (2%) |
Performance status | |
0 | 74 (35%) |
1 | 98 (46%) |
2 | 41 (19%) |
Serum LDH | |
N | 118 (57%) |
>N | 90 (43%) |
Clinical stage | |
I-II | 97 (46%) |
III-IV | 116 (54%) |
Age-adjusted IPI | |
0 | 52 (26%) |
1 | 82 (40%) |
2 | 51 (25%) |
3 | 19 (9%) |
Characteristic . | No. of Patients (%) . |
---|---|
Median age (range) | 45 yr (18-60 yr) |
Sex | |
M | 126 (59%) |
F | 89 (41%) |
Histology (WF) | |
Diffuse large cell | |
Centroblastic | 73 (34%) |
Immunoblastic | 40 (19%) |
Others | 27 (13%) |
Diffuse mixed small and large cell | 43 (20%) |
Diffuse small cell | 8 (4%) |
Follicular large cell | 12 (6%) |
Lymphoblastic | 7 (3%) |
Diffuse small noncleaved cell | 5 (2%) |
Performance status | |
0 | 74 (35%) |
1 | 98 (46%) |
2 | 41 (19%) |
Serum LDH | |
N | 118 (57%) |
>N | 90 (43%) |
Clinical stage | |
I-II | 97 (46%) |
III-IV | 116 (54%) |
Age-adjusted IPI | |
0 | 52 (26%) |
1 | 82 (40%) |
2 | 51 (25%) |
3 | 19 (9%) |